Why is getting a drug with activity against multi-drug resistant (MDR) organisms through phase III clinical trials difficult?

Question

Answer

It is expensive to source many patients with MDR infections

Answer

Phase III clinical trials against MDR organisms must be superiority trials

Answer

The drug must be effective against both MDR organisms and non-MDR organisms

Answer

Phase III trials of MDR drugs can only be performed on model organisms not humans

Crowdly